Let's talk medical research

Electronic patient-reported outcomes (often abbreviated to ePRO) are tools intended to collect patient data in clinical trials through methods such as diaries, phone apps, tablets, and other devices. These tools are useful for streamlining the work required by site staff and also create a more patient-centric environment in clinical trials.

While effectively recruiting patients is a necessary part of every study, it can also incur significant costs. Patient recruitment is one of the largest budget categories in a clinical trial, but often, this is due to ineffective outreach methods and expensive screen failures that contribute to excessive spending.

A common problem in the clinical trial industry is finding enough interested individuals to take part in a study. However, keeping patients at the center of clinical trial marketing is one of the most effective ways to address this issue. Having a deep understanding of the patient experience and considering what patients want and need from research (otherwise known as a patient-centric approach) ...

Making use of electronic patient-reported outcomes (otherwise known as ePRO) can provide a streamlined way to offer a more patient-centric experience and reduce the burden of site staff. Modern ePRO vendors can provide a range of features for clinical trial participants, communicate seamlessly with Interactive Web Response Systems, and provide support services throughout the trial.

We’re excited to share that we’ll be in attendance for the 15th annual SCOPE conference! The conference takes place in Orlando, Florida from February 11th to 14th, and will bring together some of the top companies in the clinical ops industry today.

Facilitating medical research relies on patient participation, yet research protocols often overlook the patient perspective. Improving patient centricity in clinical trials demands prioritizing the patient experience.

Recruiting patients for clinical trials is a common challenge for study sponsors conducting research. For this reason, it is often a wise strategy to work with an agency that specializes in outreach. These agencies excel at helping sponsors achieve their research goals within defined timelines and budgets.

Multiple sclerosis, often shortened to MS, is an autoimmune disorder that causes the body to attack the central nervous system. It is estimated that a million adults in the United States are living with this condition, and symptoms can include a variety of phenomena such as numbness, tingling, speech difficulties, tremors, vision issues, balance problems, and pain, all at varying degrees of ...

Volunteers play a vital role in clinical trials; nevertheless, the participant experience is often suboptimal. In an interview with Newsweek, Paul Wicks, former VP of Innovation at PatientsLikeMe once remarked, “Sometimes, it’s almost as bad as dealing with Comcast or the worst airline.” When patients are faced with overwhelming paperwork, inconvenient appointment times, and tedious symptom ...

As we move into 2024, we’d like to take a moment to highlight some of the significant achievements from the past year. Throughout 2023, we were able to reach more patients, work with more sponsors, and expand our business offerings in meaningful ways — and the impact we had serves as a great reminder of why we do what we do. In the infographic below, we’re delving deeper into the statistics that ...